We are driven by science and believe innovation requires strong collaboration to execute our vision.
Firmly grounded in science and collaboration.

Restoring immune system balance using engineered regulatory T cells (Tregs)
SonomaBio pursues a strategy to treat—and potentially cure—autoimmune and inflammatory diseases.

Our approach is being validated in the clinic.
We are evaluating our lead Treg program in clinical trials.

Our focus brings hope.
We are focused on curing autoimmune and inflammatory diseases and radically improving the lives of patients with autoimmune and inflammatory diseases.

Press Releases
SonomaBio In The News

Careers at SonomaBio
We unite our people under a shared commitment to innovation, collaboration, diversity and a sense of belonging, and finding cures for patients.